Monopar Therapeutics MNPR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $366.66M.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's market capitalization?
- Monopar Therapeutics (MNPR) reported market capitalization of $366.66M in Q1 2026.
- How has Monopar Therapeutics's market capitalization changed year-over-year?
- Monopar Therapeutics's market capitalization increased by 65.0% year-over-year, from $222.19M to $366.66M.
- What is the long-term trend for Monopar Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Monopar Therapeutics's market capitalization has grown at a 2.5% compound annual growth rate (CAGR), from $385.27M to $436.37M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.